Evidence Summary
- Evidence Level
- Moderate
- Mechanism
- Enrollment: Actual, Enrollment: Estimated, Sponsor Type: Industry, Unknown / General
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Clinical Trials
2 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT07184385 | A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition | Phase 3 | Not yet recruiting |
| NCT05682560 | Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome | Phase 2 | Completed |
Key Studies / References
- See linked studies